CAPTURE-IO

A non-interventional cross-sectional study to capture the prevalence of cardiovascular disease in patients with type 2 diabetes - an international observation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080224506

Enrollment

8000

Registered

2019-01-09

Start date

2019-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : - control material(

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed with type 2 diabetes mellitus >=180 days prior to the day of signing the informed consent.

Exclusion criteria

Exclusion criteria: Type 1 Diabetes Mellitus

Design outcomes

Primary

Measure	Time frame
safety Estimate the prevalence of established cardiovascular disease in patients with T2DM	—

Secondary

Measure	Time frame
safety Proportion of patients with high risk of CVD	—

Countries

Africa, Asia except Japan, Japan, Oceania, South America

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026